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Norovirus is now known to be the leading cause of gastroenteritis among 
children worldwide. This present report highlights the genetic diversity of noro-
virus among children less than 5 years in Southern, Nigeria. Stool specimens 
were collected from 300 children with diarrhea and analyzed for norovirus using 
conventional reverse transcriptase-Polymerase Chain Reaction. Sequencing of 
the capsid region was performed to genotype the strains. Norovirus was detected 
in 45 (11.1%) of children with diarrhea. Genogroup II norovirus was detected in 
38/45 (84.4%) patients, while genogroup I (GI) noroviruses were identified in 7/38 
(15.6%) patients. Genotype diversity was large, as demonstrated by the nine identi-
fied genotypes (2 GI and 7 GII). GII.4 was the most predominant genotype. Two 
norovirus GII.4 variants, New Orleans_2009 and Sydney_2012 were identified in 
this study. A putative novel GII.4 recombinant was also detected. This study report 
for the first time the detection of norovirus GII.17 Kawasaki strain in South–South, 
region of Nigeria.
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1. Introduction (Virology of Norovirus)
Norovirus has been identified to constitute a key biological cause of gastroen-
teritis worldwide [1]. It is also the most common cause of gastroenteritis world over 
[1]. Norovirus causes an estimated 1.1 million hospitalizations and up to 218,000 
deaths among children less than 5 years annually [1]. Clinical manifestations of 
norovirus infection are characterized by non-bloody diarrhea, vomiting and stom-
ach pain [2]. Incubation period is usually within 12 to 48 hrs after infection with the 
virus [3]. Complications are uncommon, but may include dehydration, especially in 
the young, the old, and those with other health problems [3]. Norovirus is typically 
spread by faeco-oral route, through contaminated food or water or from person to 
person [4]. Potential risk factors are poor environmental hygiene and overcrowded 
living quarters [5]. Vomiting, in particular, transmits infection effectively and 
appears to allow airborne transmission [5].
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2. Norovirus genome and genetic diversity
Taxonomically, norovirus is a positive sense RNA, non-enveloped virus in the 
family caliciviridae [6]. The genus has one species, known as Norwalk virus [6]. 
Norovirus are highly genetically diverse, Phylogenetically, they can be classified 
into 10 different genogroups (GI-GX) and several genotypes in this order; 60 
P-types (14 GI, 37 GII, 2 GIII, 1 GIV, 2 GV, 2 GVI, 1 GVII and 1 GX), with each of 
these genotypes having several genetic clusters and sub groups [7].
The genome is organized into three open reading frames (ORF) [8]. ORF 1 
encoded six non-structural proteins (NS1-NS6) and the RNA dependent RNA 
Polymerase RdRP, while ORF 2 encodes the capsid proteins-the major structural 
proteins VP1 containing the shell (S) and protruding (P) domains. The S domain 
surrounds the viral RNA and the P domain, which consists of the P2 domain, is 
linked to the S domain through a flexible hinge [9]. ORF 3 encodes a minor structural 
protein [9]. In spite of the large genetic diversity of norovirus, it is noteworthy that 
norovirus of the genotype GII.4 are responsible for a majority of infections [10, 11].
3. Norovirus recombinants
Recombination are mechanism in the evolution of RNA viruses, this creates 
changes in virus genomes by exchanging sequences, thereby generating genetic 
variation and producing new viruses [12]. RNA recombination is very common 
among RNA viruses belonging to the family picornaviridae, coronaviridae, retroviridae 
and caliciviridae [13]. Recombination commonly occurs at the ORF1-ORF2 junction 
[14] although other recombination sites have been reported. Recombination event 
is high among the GII.4 noroviruses [14]. Norovirus recombination has been recog-
nized to be a major tool it uses to evade host immune recognition [15]. Monitoring 
the incidence of rate of generation of new norovirus recombinants is a vital tool in 
the understanding of norovirus evolution and continuous global spread. Norovirus 
recombination has been linked to increased rate of generation of new norovirus geno-
types and subtypes [16], this has also hampered the possibility of a possible vaccine.
4. Justification for this study
The introduction of rotavirus vaccines throughout the world has made  
norovirus the most common aetiologic agent of gastroenteritis world over [17]. An 
update on the predominant norovirus genotype in a given population is needed for 
the development of effective vaccine. There are no data on the genetic diversity of 
norovirus among children in South–South, Nigeria. Also, there are no data on the 
prevalence of norovirus in Nigeria. Against this background, this study was con-
ducted to determine the prevalent norovirus genotypes and existence of possible 
GII.4 recombinants among children under 5 years with diarrhea in South–South, 
Nigeria.
5. Method
5.1 Study area and study population
This cross-sectional study was conducted in the period, March, 2018 to 
February, 2019. 405 children with clinical symptoms of diarrhea/gastroenteritis 
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from a pool of 2813, attending outpatient clinics of four secondary health facilities 
(Central Hospital, Warri, Central Hospital, Benin, Primary Health Centre Pessu 
and Federal Medical Centre, Yenagoa) in Delta, Edo and Bayelsa States, Niger-Delta 
region, Nigeria were randomly included. Inclusion criteria where at least 3 clini-
cal episodes of diarrhea- with an onset of 1 to 7 days whose parents or guardians 
consented for their ward/children to participate were included in this study. One 
hundred (100) asymptomatic apparently healthy age and sex matched children who 
served as controls (Figure 1).
5.2 Sample collection and processing
Stool specimens were collected into clean universal containers. Supernatant 
obtained from stool suspension of 50% in 1 ml sterile phosphate buffered saline 
were stored at -20°C for RT-PCR analysis of norovirus.
5.2.1 RNA extraction
RNA extraction was from thawed frozen samples were performed using 
AccuPrep® Viral RNA Extraction Kit (Bioneer, Daejon South Korea), following 
manufacturers instruction.
5.2.2 cDNA synthesis
cDNA synthesis was carried out on a 20 μl reverse transcription reaction of 
1.0ug of extracted RNA on 0.2 ml tubes of Accupower Cycle script RT Premix 
(Bioneer Corporation, South Korea). Standard protocols as recommended by 
manufactures were followed for cDNA synthesis.
Figure 1. 
Map of Southern Nigeria. States included in this study were Bayelsa, Delta and Edo.
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5.2.3 Polymerase chain reaction
The cDNA generated was then amplified by PCR in a 45 μL  reaction mixture  
as described in a previous study [18]. Specific primers (G1SKRCAACCCARCCA 
TTRTACA) and G1FFN (GGAGATCGCAATCTCCTGCCC) were used 
for GI genotyping, while for genotyping GII noroviruses, primers GIIFBN 
(TGGGAGGGCGATCGCAATCT) and GIISKR (CCRCCNGCATRHCCRTTRTACAT), 
respectively, were used in an RT-PCR analysis. The products were visualized on UV 
illuminator and photographed using Polaroid camera [19]. The RT-PCR used is a very 
sensitive method, it can detect as few as 5 x 106 copies per gram of stool sample. U-TaQ 
DNA polymerase (SBS genetech, Beijing, China), a high-fidelity thermostable enzyme 
that can withstand prolonged incubation at high temperature up to 95°C without 
significant loss of activity was used for this RT-PCR protocol.
5.2.4 Norovirus sequencing
The amplicons from the partial gene regions of the viral capsid genes were puri-
fied using QIAquick PCR purification kit (Qiagen Inc., Valencia, CA). Nucleotide 
sequencing was done using Big Dye ® Terminator v 3.1 Cycle sequencing kit 
(Applied Biosystems, Carlsbad, CA) on 3130 DNA genetic analyzer (Applied 
Biosystems, Carlsbad, CA), Sequences were edited using sequencher® Version 5.4.6 
DNA sequence analysis software (Gene codes Corporation, Ann Arbor, MI, USA). 
Norovirus genotypes were determined by comparison of corresponding sequences 
of norovirus strains using the online norovirus genotyping tool version 1.0. avail-
able at (www.rivm.nl/mpf/norovirus/typing tool).
5.2.5 Phylogenetic analysis
For confirmation of genotyping, nucleotide sequences obtained were aligned 
with reference sequences using MUSCLE [20]. The evolutionary history was inferred 
by using Maximum Likelihood method and Kimura 2-Parameter model. The tree 
with the highest log likelihood is shown. The percentage of trees in which the associ-
ated taxa clustered together is shown next to the branches. The tree is drawn to scale 
with the branch lengths measured in the number of substitutions per site. Accession 
Number KF307755, KF3077756, MN271357, MN271380 were used as outgroup.
6. Results
Out of the 405 children enrolled, 45 (11.1%) were positive for norovirus using 
RT-PCR (Table 1). Only norovirus genogroup I and II were recovered in this 
study, norovirus genogroup IV were not detected. Norovirus genogroup II was the 
most prevalent (84.4%) among the children (Table 2). GII noroviruses where also 
most commonly encountered among all centers included in this study (Table 3). 
Based on capsid gene sequences recovered from the 45 norovirus positive samples, 
two GI noroviruses genotype was detected in this study GI.3, 71.4% and genotype 
G1.5, 28.6% respectively. Seven genotypes of GII noroviruses were detected, 
genotypes GII.4 (63%), GII.12 (7.9%), GII.17 (7.9%), GII.6 (5.3%), GII.7 (5.3%), 
GII.14 (5.3%) and GII.2 (5.3%) (Table 4). GII.4 was found to be the most preva-
lent genotypes in all States studied, Delta (53.4%), Bayelsa (75.0%) and Edo State 
(46.2%) (Table 5).
Subtyping analysis with the norovirus genotyping tool demonstrated that the 
majority of the norovirus GII.4 recovered in this study where homologous to the 
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Location No. Tested No. Infected (%) P value
Central Hospital, Warri 83 13 (15.7) 0.0032
PHC, Pessu/ Ugbuwangwe 68 15 (22.1)
FMC Yenagoa 80 4 (5.0)
Central Hospital, Benin 99 3 (3.0)
Stella Obasanjo Hospital 75 10 (13.3)
P < 0.05.
Table 1. 
Norovirus infection detected by RT-PCR among children under 5 years from different health facilities in  
south–south region of Nigeria.





Frequency of occurrence of genogroup of norovirus in study population.
Study Centre No. Tested Nov GI Nov GII
Central Hospital, Warri 13 2 (15.4) 11 (84.6)
PHC, Pessu/Uguwangwe 15 2 (13.3) 13 (86.7)
FMC, Yenagoa 4 1 (25.0) 3 (75.0)
Central Hospital, Benin 3 1 (33.3) 2 (66.7)
Stella Obasanjo CWH, Benin 10 1 (10.0) 9 (90.0)
Table 3. 










GII. 12 3 (7.9%)
GII. 14 2 (5.3%)
GII.17 3 (7.9%)
Table 4. 
Distribution of genotypes of norovirus in study population.
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New Orleans 2009 variant 12 (50.0%), while 10 (41.7%) isolates showed homology 
to the Sydney 2012 strains. Two GII.4 sequences were unassigned. All sequences 
where further subjected to phylogenetic analysis, genotypic assignment of all 
sequences was based on bootstrap cut off values >70%. The result showed that 
norovirus GII.4 were more genetically diverse (Figure 2).
Three genetic clusters of Sydney 2009 variants where found to circulate among 
study participants, with varying sequence identity (range 74–100%). The two 
sequences that were unassigned using the genotyping tool were assigned following 
phylogenetic analysis. One GII.4 isolate (MN271364) did not cluster with either 
New Orleans or Sydney 2009 reference strains despite been assigned to be GII.4 
Sydney strain by the genotyping tool, but had genetic sequence similarity to a noro-
virus strain isolated in 1993 in Bristol (X76716), which itself is a recombinant strain 
which was neither New Orleans nor Sydney 2009 strain (Figure 3). This strain is 
however deemed a putative novel recombinant.
Genotypes Delta Bayelsa Edo
GI.3 3 (10.7) 0 2 (15.4)
GI.5 1 (3.6) 1 (25.0) 0
GII.2 1 (3.6) 0 1 (7.7)
GII.4 15 (53.4) 3 (75.0) 6 (46.2)
GII.6 1 (3.6) 0 1 (7.7)
GII.7 2 (7.1) 0 0
GII.12 2 (7.1) 0 0
GII.14 1 (3.6) 0 1 (7.7)
GII.17 1 (3.6)0 1 (7.7)
Total 28 4 13
Table 5. 
Distribution of norovirus genotypes among study centers.
Figure 2. 
Norovirus GII.4 variants among patients in this study.
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7. Discussion
A prevalence of 11.1% RT-PCR confirmed norovirus infection among children 
under 5 years of age was observed. This prevalence report is higher than the 6.7% 
in Ile –Ife, Osun State [21], but less than the 37.3% among children in Lagos, Nigeria 
[22]. This report supports the hypothesis that the prevalence of norovirus within 
Nigeria is not homogenous across communities and health centers. Hence, commu-
nity and hospital-based surveillance are needed to provide an estimate of norovirus 
burden in Nigeria. The finding of this study might imply that norovirus may be one 
of the major etiologic agents of diarrhea among children less than 5 years in South–
South region of Nigeria.
Only norovirus belonging to GI and GII genogroups were identified in this 
study, this concurs with findings from previous norovirus molecular epidemio-
logic studies [23, 24]. Norovirus genogroup II was the most commonly recovered 
norovirus in this study. This report concurs with findings from other parts of 
the World [25, 26]. This study further highlights the superior role of norovirus 
genogroup II in cases of norovirus induced gastroenteritis among children. In 
this study, GII.4 norovirus strains were most commonly detected. It has been well 
established that GII. 4 noroviruses are responsible for the majority of outbreaks 
worldwide [27].
Phylogenetic analysis revealed two GII.4 sequence variants, two Sydney 2012 
clusters and one cluster for the New Orleans 2009 strain and a putative recom-
binant GII.4 virus. It is established that new variants of GII.4 norovirus emerge 
every 1–2 years, due to genetic recombination and point mutations resulting in the 
generation of new genetic clusters, recombinants/genotypes allowing increasing 
genetic fitness and continuous spread in populations by evading host immune 
responses [28]. GII.4 Possess the largest number of intra-genotypic variants and 
recombinants [29]. It is also possible for two or more variants to co-circulate at the 
same time in a geographical location [29]. Notable GII.4 variants causing majority 
Figure 3. 
Phylogenetic tree of norovirus GII.4 identified in this study: There were a total of 1487 positions in the final 
dataset. Sequences in this study are represented with filled triangles, reference sequences are not marked. 
MN271364 had low bootstrap values, as such classified to be a putative novel recombinant.
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of pandemic diseases are the Sydney 2012, New Orleans 2009, Farmington Hills 
2002, US95/961995, Hunter 2004 and Den Haag 2009 [30]. Certain variants cause 
localized epidemics, Cairo 2007, Japan 2008 and Asia 2003 [30].
This study reports on the finding of norovirus GII.17 among children in 
Southern, Nigeria for the first time, this genotype is known to be very virulent 
[17]. First documented evidence of emergence of GII.17 occurred in the winter of 
2014–2015 in Asia [31].
The finding of this study provides evidence of the existence of diverse genetic 
subtypes of norovirus in our locality. This data has illuminated the epidemiological 
profile of norovirus induced diarrhea/gastroenteritis in our locality.
7.1 Study limitations
Whole genome sequencing of both the major capsid protein and polymerase 
protein (RDrP) of the putative novel recombinant identified could not be per-
formed because of lack of funds. This would have help to inform on the proper 
assignment of the putative novel recombinants as a novel genotype. Analysis of 
recombination breakpoints sites, homology model, evolutionary and phylogeo-
graphic relationships with reference will help provide greater information on the 
novel recombinants identified in this study.
7.2 In conclusion
Prevalence of RT-PCR confirmed norovirus infection among children with 
gastroenteritis in our locality was 11.1%. Norovirus genogroups I and II were 
the norovirus recovered in this study. G11.4 noroviruses were more prevalent, 
rare norovirus genotypes GII.2 and GII.17 were also encountered. The prevail-
ing GII.4 variants in our study area belong to the New Orleans 2009 and Sydney 
2012 strain, a putative novel GII.4 recombinant was encountered among study 
participants.
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